IE883807L - A process for the enzymatic hydrolysis of ó-aminoadipinyl-monoamino compounds - Google Patents

A process for the enzymatic hydrolysis of ó-aminoadipinyl-monoamino compounds

Info

Publication number
IE883807L
IE883807L IE883807A IE380788A IE883807L IE 883807 L IE883807 L IE 883807L IE 883807 A IE883807 A IE 883807A IE 380788 A IE380788 A IE 380788A IE 883807 L IE883807 L IE 883807L
Authority
IE
Ireland
Prior art keywords
glutamyltranspeptidase
gtp
hydrolysis
aminoadipinyl
formula
Prior art date
Application number
IE883807A
Other versions
IE62566B1 (en
Inventor
Klaus Sauber
Werner Aretz
Original Assignee
Timothy Gerard Vaughan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Timothy Gerard Vaughan filed Critical Timothy Gerard Vaughan
Publication of IE883807L publication Critical patent/IE883807L/en
Publication of IE62566B1 publication Critical patent/IE62566B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/02Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

gamma -Glutamyltranspeptidase, which can be prepared by fermentation, can be used to hydrolyse alpha -aminoadipinyl-monoamino compounds, especially D-( delta )- alpha -aminoadipinyl-7-aminocephalosporanic acid.

Description

9 ■; 6 6 - 1 - /f-Glutamyltranspeptidases (GTP hereinafter) play an i m — portant part in amino acid metabolism and in the glutathione cycle in animal tissues and in microorganisms C^eth. Enzymol. 77 , 237 (1981)D. They are responsible tor 5 the transport of various amino acids in the form of their (j -glutamyl derivatives,, the formation of polyglutamic acid in Bacilli,, and the breakdown of glutathione (^-glutamyl-cysteinyl-glyc ine), It has already been proposed (EP 0,275,901) to use GTP 10 to hydrolyze adipinyl- or glutaryl-monoamino compounds™ It has now been found,, surprisingly, that ^GTP catalyzes the hydrolys i s of c-aminoadipinyl-monoamino compounds of the formula I HOOC-CH-(CH2)3-C-NH-R1 (I) NH2 0 15 in which 1 6? denotes amino acids, dipept ides, cephems, cephams or derivatives thereof.
This is all the more surprising because it has hitherto been assumed that neither C 4 nor C § side-chains ere 20 accepted by the active center of GTP (see Agric. Biol. Chen. 42, 1978, pages 371 - 81).
Hence the invention relates to: 1. A ^"-glutamyltranspept idase having the following properties - 2 - - a molecular weight of 40,000 to 80^000, - an isoelectric point at pH 4.4 to 5.9, - for L-ff-glutamylparanitroanilide as substrate a pH optimum in the range 6-5 to 10, and a Km of 9 to 36 iiM at pH 8, and - hydrolysis of cs-aminoadipinyl-monoamino compounds of the formula I HOOC-CH-(CH?)o-C-NH-R1 (I) I ^ J II NH2 O in which 1 R denotes amino acids,, dipeptides, cephems, cephams or- derivatives thereof- 15 2. A process for the preparation of the ^glutamyltrans-peptidase having the properties mentioned in 1„, which comprises cultivation of bacteria of the genera Pseudomonas, Proteus,, Arthrobacter and Bacillus in a nutrient medium until the said GTP accumulates in 20 the nutrient medium. 10 3. The use of the jT~glutamyltranspeptidase having the properties mentioned in 1 „ for the hydrolysis of <*-aminoadipinyl-monoamino compounds of the formuLa I. 25 The invention is described in detail hereinafter^ especially in its preferred embodiments. The invention is furthermore defined in the patent claims* 30 The glucernyltranspept idase (/p?GTP) catalyzes the hydrolysis of a-aminoadipinyl-monoamino compounds of the formula I, as defined above^ to give the corresponding acid and the monoamino compound* 7-Aminocephalosporanic T> acid derivatives are preferably used as substrate. 35 G> The enzyme occurs in the periplasm of microorganisms and extracellularly and can be characterized by a molecular weight of 40,,,000 to 80^000,, preferably 50^000 to 70,.00Q, especially 55,000 to 65,000, and by an isoelectric point which is at a pH of 4 = 4 to 5.9, preferably 4.8 to 5.5. The pH optimum for L-^-glutamylparanitroanilide as substrate is in the pH range 6.5 to 10. The transpeptidase according to the invention has a Km for the same substrate of 9 to 36 y M , preferably 15 to 20 y H , in particular 17.8 yH, at pH 8.
The .J"GTP according to the invention is irreversibly inhibited in the presence of azaserine or iodoacetamide. The enzyme shows reversible inhibition in the presence of copperf mercury and a mixture of serine and borate,, as well as in the presence of 7-aminocephalosporanic acid.
The GTP is prepared with the aid of microorganisms, as also described in European Patent Application EP 0,275,901. In this process^ bacteria, especially of the genera Pseudomonas, Proteus,, Arthrobacter and Bacillus, are cultivated in a nutrient medium until ^-GTP accumulates in the nutrient medium. Suitable examples are: Pseudomonas putida ATCC 17390, Pseudomonas aeruginosa MCTC 10701, Proteus vulgaris ATCC 9634, Arthrobacter paraf ineus ATCC 31917 cs well as Pseudomonas fregi DSffl 3881 and Bacillus subtilis I F0 3025. The ensyme is particularly preferably obtained from Bac. subtilis IFO 3025. Mutants and variants of the said microorganisms are also suitable.
The microorganisms are cultured aerob i c a 11 y, singly or in mixed culture^ for example submerged with shaking or stirring in shaken flasks or fermenters, where appropriate with air or oxygen being passed in. The fermentation can take place in a temperature range from about 20 to 37° C , preferably at about 25 to 30°C, in particular at 28 to 30°C» Fermentat ion is carried out in a pH range between 5 and 8.5, preferably between 5.5 and 8 „ 0 Under these conditions, the culture broth shows considerable accumulation of the enzyme in general after 1 to 3 days. Syn-thesis of the A -GTP starts in the late log phase and reaches its maximum in the stationary phase of growth.
The production of the peripLasmic enzyme can be followed with the aid of activity assays by HPLC analysis or photometry.
The nutrient solution used to produce the /j^GTP contains 0.2 to 5 % , preferably 0.5 to 2 %, organic nitrogen compounds and inorganic salts. Suitable organic nitrogen compounds are; amino acids, peptones, furthermore meat extracts, milled seeds, for example of corn, wheat, beans, soybeans or the cotton plant, distillation residues from the manufacture of alcohol, meat meals or yeast extracts. Examples of inorganic salts which the nutrient solution can contain are chlorides, carbonates, sulfates or phosphates of the alkali metal or alkaline earth metals, iron, zinc and manganese, but also ammonium salts and nitrates.
The addition of assimilable carbohydrates increases the yield of biomass. Carbohydrates are also added in the abovement ioned concentrations. It is possible to add as preferred carbon source for example sugars, such as glucose or sucrose, as well as carbohydrate-containing natural products such as malt extract, to the nutrient solution.
Although the optimal fermentation conditions differ for each microorganism, either they are already known to those skilled in the art or they can be established in easy preliminary tests.
Purification can be carried out by classical processes via lysozyme digestion, ammonium sulfate precipitation, and ion exchange and gel permeation chromatography. The enzyme can be coupled by conventional methods (Colowick and Kaplan, Heth. Enzymol., vol. XLIV).
It is possible to use for the enzymatic reaction both 10 15 20 25 30 - 5 - whole cells in free or immobilized form, with the addition of 8-lactamase inactivators, for example clavulanic acid or thienamycin, and the isolated enzyme which can also be carrier-bound. Examples of suitable materials for the immobilization of whole cells are chitosan, alginate^ K-carrsgsenan, polyacrylohydrazides-and other known substances from processes known from the literature (K, Venkatsubraraanian, Immob. Cells (19 79), ACS Symposium Series,, page 106) .
The hydrolysis reaction is most suitably carried out at about pH 6.6 to 8 and at a temperature of about 28 to 38°C The preferred compound of the formula I is that in which A R1 denotes the radical COOH in which R ^ is hydrogen, OH or -0-C-CH-s.
I The (y-GTP has industrial importance in particular for obtaining 7-aminocepha Iosporanic acid from cephalosporin C . To date however,, a yeast (Trigonopsis variabilis) has always been used to generate from cephalosporin C glutaryl-7-aainocephalosporanic acid which only then could be hydro ly^ed enzymatically,, in a second reaction step,, to give 7 -aesinocephalosporanic acid. It is now possible with the process according to the invention to prepare 7-am i no-cepha Iosporanic acid from cephalosporin C in a single step The invention is described in more detail in the examples which follow. Unless otherwise indicated, percentage data relate to weight.
Example 1 The GTP-produc ing microorganism strains are maintained on agar slants of the following compositions - 6 - Glucose 1 % Casein peptone 0. 4 % Heat extract 0. 4 % Yeas t extract 0. 05 % Liver extract 0. 05 % NaCl 0. 25 «!/ A pH 7.2 Ths slant tubes are incubated at 28°C for 2 days. The 10 cells are then rinsed off with 10 ml of physiological saline, and 1 ml of this suspension is used to inoculate a 50 ml preculture of the following composition in an Erlen in eyer flask of capacity 300 mis 15 Peptone Malt extract pH 7.0 The flask is incubated at 30°C and 190 rpm in a rotary 20 shaker for 24 hours. 2.5 ml of this culture are used as inoculum for 50 ml of main culture: Bacilli Peptone 0.12 % 25 Yeast extract 0.12 % Glucose 0.25 % Ha I ac t at e (60 %) 5.6 m I iH^Cl 0.12 X K2HPO4 0.12 % 30 KH2PO4 0.034 % Mgso4 X 7 h2o 0.025 % MaC I 0.5 % KCL 0.5 cy AJ CaC12 x Z h2o 0.0015 w /o 35 HnCIp x 4 h2o 0.0007 o* FeCNH^Jci t r a t e 0.00015 % I fo 0.5 % The culture is incubated at 28°C and a shaking frequency of 190 rpm for 2 4 hours and is then harvested by centrifugal ion.
(^-G TP activities of some strains are Listed in the table which follows: Strain ^-GTP (mil/ml culture solution) B. subtilis IFO 3025 60 IF0 3013 15 IFO 3335 25 Example 2 A preculturs with B a c „ subtilis IFO 3025 is cultured in an a logy to Example 1- 50 ml of this culture are used as inoculum for 2 I of main culture solution in a 5 I fer-raenter. The strain is cultured at 34°C and a partial pressure of oxygen of 70 % „ The formation of the /j-GTP is followed by photometry, and the culture is harvested at the maximum enzyme titer. Under the given conditions, a ^-GTP titer of 150 mU/ml of culture solution is reached.
Example 3 9 1 of culture solution are separated by means of cross-flow filtration (exclusion limit 300,000 dalton) into culture filtrate and biomass. The culture filtrate obtained in this way contains a GTP activity of 1350 U„ The enzyme is precipitated by addition of ammonium sulfate to 70 % saturation and is taken up again in 1/10 of the volume. After dialysis against 20 mini tris, pH 8.0, the enzyme is further purified on a DEAE-cellulose column (DE 52, Whatman). The active eluates are combined and concentrated. A fp-GTP product obtained in this way (con-taining about 25 U of A -GTP/ml) is used for the conversions Example 4 - 8 - The following mixture is chosen for preparative conversion of deacetyL-CPC: 100 y I of 40 mM deacetyl-CPC dissolved in 20 m M potassium phosphate buffere pH 7.3,, are incubated at a temperature of 33°C . 10 Up to 16 % deacetyI-7-aminocepha Iosporanic acid are produced under the chosen conditions.
Example S 15 With incubation conditions analogous to those detailed in Example 4 3 % 7-aminocephalosporanic acid is liberated from CPC.
E x ampIe 6 5 100 yl of enzyme concentrate prepared as in Example 3,, and 20 Determination of -GTP activity a) HPLC assay 25 50 y I of 80 m M deacetyl-CPC are mixed with 100 to 140 Ul of 250 mH potassium phosphate buffer^ pH 5.0^ and 10 to 50 yl of enzyme solution and incubated at 33°C„ A 20 yl-sample is taken every 10 minutes. The reaction 30 is stopped with 20 y I of methanol. It is centrifuged and diluted with water in the ratio 1:10. A 10 y I sample is investigated by HPLC for the 7-aminocephalosporanic acid content. 35 Stationary phases C — 18 silica gel Mobile phases KHgPO^ 50 mfi in h^O/MeOH (80:20) + 0.001 % tetrabutyIammonium sulfate b) Photoniet r i c assay 600 yl of L- -gIutamy I-p-nitroaniIide (166 yH) - 9 - 300 yl of potassium phosphate buffer, pH 5„ 7, 50 mM and 100 pi of culture solution are mixed together and incubated at 37°C „ E 1 405 = 9620 mo I -cm

Claims (1)

1. Patent claims - 10 - Glutamyltranspeptidase having the following propert ies - a molecular weight of 40,000 to 80,000,, - an isoelectric point at pH 4,4 to 5.9, - for L-/j"1glutamylparanitroanilide as substrate a pH optimum in the range 6.5 to 10, and a Km of 9 to 36 pin at pH 8,, and - hydrolysis of a~aminoadipinyI-monoamino compounds of the formula I HOOC-CH- (CH?) -,-C-NH-R1 (I) I ^ J l| NH2 o 1 R denotes amino acids, dipeptides, cephems, cephams in which 1 R denot or derivatives thereof. A process for the preparation of the ^-glutamyltranspeptidase as claimed in claim 1, which comprises cultivation of bacteria of the genera Pseudomonas, Proteus, Arthrobacter and Bacillus in a nutrient medium until ^p-GTP as claimed in claim 1 accumulates in the nutrient medium. The process as claimed in claim 2 , wherein the glutamyltranspeptidase is obtained by cultivation of B. subtilis IFO 3025. The use of the ^glutamyltranspeptidase as claimed in claim 1 for the hydrolysis of ct-aminoadipinyl-monoa#ino compounds of the formula I hooc-ch-(ch2)3-c-nh-r1 (i) nh2 o - 11 1 R denotes amino acids, dipeptides, cephesns, cephams or in which 1 R denot derivatives thereof The use as claimed in claim 4r wherein the compound i of the formula I in which R denotes the radical 2 in which R is hydrogen^ OH or -O-C-GHj is hydrolyzed. 0 6- The use as claimed in claim 4 or 5, wherein the hy drolysis is carried out at a pH of 6.6 to 8.0. 10 7 - The use as claimed in one or more of claims 4 to 6, wherein the hydrolysis is carried out at 28 to 38°C. 8. 7> -Glutamyltranspeptidase according to claim 1, substantially as hereinbefore described. 9. h process according to claim 2 for the preparation of 15 ^-glutamyltranspeptidase, substantially as hereinbefore described and exemplified. 10. #-GlutamyItranspeptidase whenever prepared by a process claimed in a preceding claim. 11. Use according to claim 4, substantially as hereinbefore 20 described. f. r. kelly & co., agents for the applicants.
IE380788A 1987-12-21 1988-12-20 A process for the enzymatic hydrolysis of alpha-a minodipinyl-monoamino compounds. IE62566B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873743323 DE3743323A1 (en) 1987-12-21 1987-12-21 PROCESS FOR ENZYMATIC HYDROLYSIS OF (ALPHA) -AMINOADIPINYL-MONOAMINO COMPOUNDS

Publications (2)

Publication Number Publication Date
IE883807L true IE883807L (en) 1989-06-21
IE62566B1 IE62566B1 (en) 1995-02-08

Family

ID=6343136

Family Applications (1)

Application Number Title Priority Date Filing Date
IE380788A IE62566B1 (en) 1987-12-21 1988-12-20 A process for the enzymatic hydrolysis of alpha-a minodipinyl-monoamino compounds.

Country Status (14)

Country Link
EP (1) EP0321849B1 (en)
JP (1) JP2816167B2 (en)
KR (1) KR0149656B1 (en)
AT (1) ATE91711T1 (en)
AU (1) AU616450B2 (en)
CA (1) CA1317246C (en)
CZ (1) CZ283529B6 (en)
DE (2) DE3743323A1 (en)
DK (1) DK710588A (en)
ES (1) ES2058224T3 (en)
HU (1) HU202917B (en)
IE (1) IE62566B1 (en)
PT (1) PT89282B (en)
ZA (1) ZA889442B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE90382T1 (en) * 1987-01-17 1993-06-15 Hoechst Ag USE OF GAMMA GLUTAMYL TRANSPEPTIDASE.
US5229274A (en) * 1989-06-27 1993-07-20 Merck & Co., Inc. Gene encoding one step cephalosporin C amidase and expression thereof in recombinant bacillus
US5104800A (en) * 1989-06-27 1992-04-14 Merck & Co., Inc. One-step cephalosporin c amidase enzyme
JP3036775B2 (en) * 1990-02-07 2000-04-24 協和醗酵工業株式会社 Method for producing r-glutamyl transpeptidase
JPH04281787A (en) * 1991-03-04 1992-10-07 Yoshihiro Asada Production of gamma-glutamyltranspeptidase
KR100227711B1 (en) * 1991-10-15 1999-12-01 한스 발터 라벤 Novel bioprocesses for preparing 7-aca and 7-adac

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6121097A (en) * 1984-07-10 1986-01-29 Asahi Chem Ind Co Ltd Preparation of 7-aminocephalosporanic acid and derivative thereof
ATE90382T1 (en) * 1987-01-17 1993-06-15 Hoechst Ag USE OF GAMMA GLUTAMYL TRANSPEPTIDASE.

Also Published As

Publication number Publication date
DK710588A (en) 1989-06-22
HU202917B (en) 1991-04-29
JPH01199576A (en) 1989-08-10
PT89282A (en) 1989-12-29
ZA889442B (en) 1989-08-30
DE3743323A1 (en) 1989-06-29
KR0149656B1 (en) 1998-08-17
EP0321849B1 (en) 1993-07-21
DK710588D0 (en) 1988-12-20
ATE91711T1 (en) 1993-08-15
AU2732388A (en) 1989-06-22
EP0321849A3 (en) 1990-09-12
KR890010211A (en) 1989-08-07
EP0321849A2 (en) 1989-06-28
JP2816167B2 (en) 1998-10-27
DE3882503D1 (en) 1993-08-26
IE62566B1 (en) 1995-02-08
CA1317246C (en) 1993-05-04
ES2058224T3 (en) 1994-11-01
CZ283529B6 (en) 1998-04-15
CZ847388A3 (en) 1997-12-17
HUT49168A (en) 1989-08-28
AU616450B2 (en) 1991-10-31
PT89282B (en) 1993-07-30

Similar Documents

Publication Publication Date Title
US3945888A (en) Method for the production of cephalosporins
US4774179A (en) Process for preparing a 7-aminocephalosporanic acid compound
Morin et al. Production of hydantoinase from Pseudomonas fluorescens strain DSM 84
US4990444A (en) γ-glutamyltranspeptidase, its preparation and its use
US3871963A (en) Microbial protease and preparation thereof
US4517299A (en) Acetylesterases
US7888079B2 (en) Nε-acyl-L-lysine-specific aminoacylase
IE883807L (en) A process for the enzymatic hydrolysis of ó-aminoadipinyl-monoamino compounds
JPS6322188A (en) Novel l-aminoacylase
JP4300289B2 (en) Hydrolysis or dehydration condensing enzyme, method for producing the enzyme, and method for synthesizing amide using the enzyme
JP2840134B2 (en) Novel aminoacylase and method for producing the same
US5153128A (en) Heat-resistant β-galactosyltransferase, its production process and its use
JP3093039B2 (en) Novel esterase A and method for producing the same
EP0243167A1 (en) A novel microorganism, a novel esterase and method for preparing the same
US4732857A (en) Process for producing enzyme capable of inactivating cytosolic aspartate aminotransferase isozyme
US5902736A (en) Process for the production of D-α-amino acids by hydrolysis of the corresponding N-carbamyl derivative
JPH0898683A (en) 7-aminocephalosporanic acid esterase
JPH09107959A (en) Malate dehydrogenase and its production
JPH0574353B2 (en)
JPH01265896A (en) Production of d-alpha-amino acid
JPH0761263B2 (en) Novel esterase and method for producing the same
JPH0634715B2 (en) Isomaltose degrading enzyme and method for producing the same
JPH07274985A (en) Production of d-gamma-methylleucine

Legal Events

Date Code Title Description
MM4A Patent lapsed